相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclax
M. Espona-Fiedler et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process
Mohamed Rahmani et al.
BLOOD (2012)
Prodigiosin down-regulates SKP2 to induce p27KIP1 stabilization and antiproliferation in human lung adenocarcinoma cells
Hsin-Ying Hsieh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Exploration of Protein Conformational Change with PELE and Meta-Dynamics
Benjamin P. Cossins et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Evaluation of Diverse α/β-Backbone Patterns for Functional α-Helix Mimicry: Analogues of the Bim BH3 Domain
Melissa D. Boersma et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Prodigiosin-induced cytotoxicity involves RAD51 down-regulation through the JNK and p38 MAPK pathways in human breast carcinoma cell lines
Chien-Hsing Lu et al.
TOXICOLOGY LETTERS (2012)
Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
Bonsu Ku et al.
CELL RESEARCH (2011)
Synthetic Prodiginine Obatoclax (GX15-070) and Related Analogues: Anion Binding, Transmembrane Transport, and Cytotoxicity Properties
Borja Diaz de Grenu et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
The BH3 α-Helical Mimic BH3-M6 Disrupts Bcl-XL, Bcl-2, and MCL-1 Protein-Protein Interactions with Bax, Bak, Bad, or Bim and Induces Apoptosis in a Bax- and Bim-dependent Manner
Aslamuzzaman Kazi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
Leena Gandhi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress
L. Dong et al.
ONCOGENE (2011)
Molecular dynamics study of small molecule inhibitors of the Bcl-2 family
Stephane Acoca et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis
Sameer A. Parikh et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
New Insights on the Antitumoral Properties of Prodiginines
R. Perez-Tomas et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Structural Insights into the Design of Small Molecule Inhibitors That Selectively Antagonize Mcl-1
Paul H. Bernardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
BCL-2 Family Inhibitors Enhance Histone Deacetylase Inhibitor and Sorafenib Lethality via Autophagy and Overcome Blockade of the Extrinsic Pathway to Facilitate Killing
Aditi Pandya Martin et al.
MOLECULAR PHARMACOLOGY (2009)
Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines
Tsing-Fen Ho et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman et al.
PLOS BIOLOGY (2009)
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)
Marina Konopleva et al.
CANCER RESEARCH (2008)
Mimicking the BH3 domain to kill cancer cells
T. Ni Chonghaile et al.
ONCOGENE (2008)
Structural plasticity underpins promiscuous binding of the prosurvival protein a1
Callum Smits et al.
STRUCTURE (2008)
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells
Jiannong Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis
Mai Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
Suzanne Trudel et al.
BLOOD (2007)
Structural insights into the degradation of Mcl-1 induced by BH3 domains
Peter E. Czabotar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
Simon N. Willis et al.
SCIENCE (2007)
Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-30 activity in human breast cancer cells
Vanessa Soto-Cerrato et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Crystal structure of ABT-737 complexed with Bcl-x(L): implications for selectivity of antagonists of the Bcl-2 family
E. F. Lee et al.
CELL DEATH AND DIFFERENTIATION (2007)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins
D. Zhai et al.
CELL DEATH AND DIFFERENTIATION (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
U Maurer et al.
MOLECULAR CELL (2006)
PELE: Protein energy landscape exploration. A novel Monte Carlo based technique
KW Borrelli et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis et al.
GENES & DEVELOPMENT (2005)
Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands
CL Day et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen et al.
MOLECULAR CELL (2005)
Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin
V Soto-Cerrato et al.
BIOCHEMICAL PHARMACOLOGY (2004)
分享论文
